Disrupting the Sleep Lab: Polaris Launches At-Home Apnea Care

BALTIMORE, MD – July 29, 2026 – For millions suffering from the exhaustion and serious health risks of sleep apnea, the path to diagnosis has long been a frustrating marathon of referrals, insurance hurdles, and months-long waits for an overnight stay in a clinical lab. Today, a new Baltimore-based company, Polaris, is launching a virtual sleep clinic with a bold promise: to shrink that timeline from months to less than a week, all from the comfort of a patient’s own bed.

Backed by Healthworx Studio, the innovation arm of CareFirst BlueCross BlueShield, Polaris is entering the burgeoning telehealth market with a model designed to dismantle the most significant barriers in sleep medicine. By shipping advanced diagnostic devices directly to patients and managing care through a continuous telehealth platform, the company aims to redefine not just the speed but the very nature of sleep apnea treatment.

Breaking the Bottleneck in Sleep Medicine

The traditional system for diagnosing sleep apnea is notoriously inefficient. Industry data reveals that patients can wait over 60 days just for an appointment for an in-lab polysomnography (PSG), the gold-standard diagnostic test. This overnight study requires patients to sleep in an unfamiliar environment, wired with sensors to monitor brain waves, heart rate, and breathing. The logistical hurdles and delays mean that a vast majority of the estimated 22 million Americans with sleep apnea remain undiagnosed and untreated.

"Untreated sleep apnea doesn't just make you tired - it increases your risk of serious conditions like stroke, cardiovascular disease, and more," said Dr. Brent Jacobus, Medical Director at Polaris, in the company's announcement. "Treating this condition shouldn't be a luxury."

Polaris's model directly confronts this bottleneck. Instead of requiring an in-lab stay, the company utilizes Home Sleep Apnea Tests (HSATs). These FDA-cleared devices, which measure key metrics like airflow, respiratory effort, and oxygen saturation, are shipped directly to a patient’s home. The patient performs the test on their own schedule, and the data is uploaded for review by Polaris specialists, often the very next day. This digital-first approach slashes the diagnostic timeline, enabling a treatment plan to be established in under a week.

This acceleration is particularly critical for individuals in professions with non-traditional hours. "We designed Polaris to meet patients exactly where they are - whether they are shift workers, truck drivers, or anyone with a demanding schedule - providing rapid, high-quality care without the typical delays," explained Tina Garrett, a Care Coordinator at the company.

While HSATs are not a replacement for in-lab PSGs in all cases—particularly for patients with complex comorbidities or suspected non-apnea sleep disorders—they are highly accurate for diagnosing moderate to severe obstructive sleep apnea, which represents the majority of cases. By streamlining the process for this large patient population, the system frees up limited in-lab resources for the most complex diagnoses.

Beyond CPAP: A New Model for Patient-Centric Care

Beyond speed, Polaris is positioning itself as a champion of holistic, unbiased treatment. A common criticism of the sleep medicine industry is the commercial incentive structure that can funnel patients directly toward CPAP (Continuous Positive Airway Pressure) machines, which are not a one-size-fits-all solution. Many clinics have financial ties to durable medical equipment (DME) providers, creating a potential conflict of interest.

Polaris explicitly breaks from this model by referring patients to independent vendors for any necessary equipment. This allows its clinical team to recommend a broader, evidence-based range of treatments tailored to the individual. Options extend beyond CPAP to include custom-fit oral appliances, which reposition the jaw to keep the airway open; positional therapies for those whose apnea is worse when sleeping on their back; and even advanced, FDA-approved hypoglossal nerve stimulators for select patients who cannot tolerate CPAP.

This patient-centric philosophy extends into long-term management. Non-adherence is a major challenge in sleep apnea treatment, with some studies showing that up to 50% of patients abandon their CPAP therapy within the first year. Polaris aims to combat this with a "concierge-style" continuous care model, providing ongoing clinical support, setup assistance, and structured telehealth follow-ups at 30, 90, and 180 days. This high-touch approach is critical for troubleshooting issues, adjusting therapies, and providing the coaching needed to integrate treatment into a patient’s life successfully.

"Effective chronic disease management requires a partnership, not a transaction," noted one healthcare strategy analyst. "By building in structured follow-up and removing commercial bias from treatment recommendations, this model addresses two of the biggest reasons why sleep apnea care fails."

The Technology and Strategy Behind the Disruption

Polaris enters a competitive but rapidly expanding virtual care landscape. Companies like Loft Sleep (now part of ResMed) and Sleep Doctor have already established a market for at-home testing. However, Polaris’s strategic foundation and its explicit commitment to being treatment-agnostic serve as key differentiators.

The company's launch from Healthworx Studio provides more than just initial funding; it offers deep institutional knowledge and a strategic connection to a major regional insurer. This relationship could prove invaluable for navigating the complex web of state-based regulations and insurance reimbursement policies, which remain a significant hurdle for many digital health startups. By initially focusing on the DC, Maryland, and Virginia markets, Polaris can refine its model within the CareFirst ecosystem before pursuing broader regional expansion.

The regulatory environment itself has become more favorable. The widespread adoption of telehealth during the pandemic has led many states, including those in Polaris’s initial territory, to enact laws mandating insurance coverage for virtual services at parity with in-person care. Furthermore, major payers, including Medicare, now widely cover HSATs for appropriate patients, validating the clinical and economic viability of at-home diagnostics.

The core challenge for Polaris will be to execute on its promise of a superior, seamless patient experience while scaling its operations. It must prove that its high-touch, concierge model is not only clinically effective but also financially sustainable. By combining proven at-home technology with a conflict-free, continuous care framework, Polaris is making a compelling case that the future of sleep medicine is faster, more accessible, and built entirely around the patient.